Single-cell analysis is essential for understanding complex biological systems, but conventional methods like flow cytometry are constrained by spectral overlap and limited detection channels. While mass cytometry (CyTOF) addresses these issues using metal isotopes, its multiplexing capacity is capped by the finite number of tags, restricting cellular profiling in areas such as immunology, oncology, and stem cell research.
Our solution leverages two-dimensional (2D) nanomaterials, specifically MXenes, as novel mass tags for CyTOF and high-dimensional imaging. These materials provide unique, non-overlapping mass signatures, significantly expanding the number of detectable parameters per cell and enabling deeper, more comprehensive analysis while maintaining compatibility with existing platforms.

TRL (Technology Readiness Level)

TRL 7 / 9

Inventors

Delogu Lucia Gemma

Fusco Laura

Gogotsi Yury

Download the brochure

  • Multifunctional nanoparticles based on metal nanalloys for diagnostic and therapeutic uses

    The invention relates to nanoparticles (NPs) comprising a metal alloy and a biocompatible organic stabilizer, useful in the diagnosis and therapy of pathological conditions such as cancer. The alloy NPs possess the characteristics required to be employed as contrast agents...

  • Method for controlling the delivery of insulin

    Currently diabetic patients wear sensors that track and communicate their glucose levels, as well as alarm when they go out of range. The patient, if aware and shrewd, then injects the correct amount of insulin based on the glycemic level...

  • Glioblastoma multiforme: a new prognostic index of survival

    Glioblastoma (GBM) is the most common brain cancer among adults and patients and has an overall survival (OS) of 15 months. Nowadays brain tumours are not taken in evaluation in relation to the brain area in which they are located....

Subscribe to newsletter

Follow the activities promoted by UniSMART Foundation